Literature DB >> 22226792

A rapid and quantitative method for the evaluation of V gene usage, specificities and the clonal size of B cell repertoires.

A M Vale1, J B Foote, A Granato, Y Zhuang, R M S Pereira, U G Lopes, M Bellio, P D Burrows, H W Schroeder, A Nobrega.   

Abstract

The quantitative simultaneous description of both variable region gene usage and antigen specificity of immunoglobulin repertoires is a major goal in immunology. Current quantitative assays are labor intensive and depend on extensive gene expression cloning prior to screening for antigen specificity. Here we describe an alternative method based on high efficiency single B cell cultures coupled with RT-PCR that can be used for rapid characterization of immunoglobulin gene segment usage, clonal size and antigen specificity. This simplified approach should facilitate the study of antibody repertoires expressed by defined B cell subpopulations, the analysis of immune responses to self and nonself-antigens, the development and screening of synthetic antibodies and the accelerated study and screening of neutralizing antibodies to pathogenic threats. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22226792      PMCID: PMC3653430          DOI: 10.1016/j.jim.2011.12.005

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells.

Authors:  A B Kantor; C E Merrill; L A Herzenberg; J L Hillson
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

2.  Functional diversity and clonal frequencies of reactivity in the available antibody repertoire.

Authors:  A Nobrega; A Grandien; M Haury; L Hecker; E Malanchère; A Coutinho
Journal:  Eur J Immunol       Date:  1998-04       Impact factor: 5.532

3.  Frequent occurrence of identical heavy and light chain Ig rearrangements.

Authors:  K J Seidl; J D MacKenzie; D Wang; A B Kantor; E A Kabat; L A Herzenberg; L A Herzenberg
Journal:  Int Immunol       Date:  1997-05       Impact factor: 4.823

4.  A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis.

Authors:  L S Collins; K Dorshkind
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

5.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

Authors:  C Taswell
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

6.  Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning.

Authors:  Thomas Tiller; Eric Meffre; Sergey Yurasov; Makoto Tsuiji; Michel C Nussenzweig; Hedda Wardemann
Journal:  J Immunol Methods       Date:  2007-10-31       Impact factor: 2.303

7.  Clonal growth and maturation to immunoglobulin secretion in vitro of every growth-inducible B lymphocyte.

Authors:  J Andersson; A Coutinho; W Lernhardt; F Melchers
Journal:  Cell       Date:  1977-01       Impact factor: 41.582

8.  Genetic control of the B cell response to LPS: opposing effects in peritoneal versus splenic B cell populations.

Authors:  A M Vale; E Hayashi; A Granato; H W Schroeder; M Bellio; Alberto Nobrega
Journal:  Immunogenetics       Date:  2009-11-24       Impact factor: 2.846

9.  A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood.

Authors:  Aishun Jin; Tatsuhiko Ozawa; Kazuto Tajiri; Tsutomu Obata; Sachiko Kondo; Koshi Kinoshita; Shinichi Kadowaki; Kazuo Takahashi; Toshiro Sugiyama; Hiroyuki Kishi; Atsushi Muraguchi
Journal:  Nat Med       Date:  2009-08-16       Impact factor: 53.440

10.  Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation.

Authors:  M Shlomchik; M Mascelli; H Shan; M Z Radic; D Pisetsky; A Marshak-Rothstein; M Weigert
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  5 in total

1.  The link between antibodies to OxLDL and natural protection against pneumococci depends on D(H) gene conservation.

Authors:  Andre M Vale; Pratibha Kapoor; Greg A Skibinski; Ada Elgavish; Tamer I Mahmoud; Cosima Zemlin; Michael Zemlin; Peter D Burrows; Alberto Nobrega; John F Kearney; David E Briles; Harry W Schroeder
Journal:  J Exp Med       Date:  2013-05-06       Impact factor: 14.307

2.  Immunoglobulin analysis tool: a novel tool for the analysis of human and mouse heavy and light chain transcripts.

Authors:  Tobias Rogosch; Sebastian Kerzel; Kam Hon Hoi; Zhixin Zhang; Rolf F Maier; Gregory C Ippolito; Michael Zemlin
Journal:  Front Immunol       Date:  2012-06-28       Impact factor: 7.561

3.  Violation of an evolutionarily conserved immunoglobulin diversity gene sequence preference promotes production of dsDNA-specific IgG antibodies.

Authors:  Aaron Silva-Sanchez; Cun Ren Liu; Andre M Vale; Mohamed Khass; Pratibha Kapoor; Ada Elgavish; Ivaylo I Ivanov; Gregory C Ippolito; Robert L Schelonka; Trenton R Schoeb; Peter D Burrows; Harry W Schroeder
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

4.  Microbial symbionts regulate the primary Ig repertoire.

Authors:  Yuezhou Chen; Neha Chaudhary; Nicole Yang; Alessandra Granato; Jacob A Turner; Shannon L Howard; Colby Devereaux; Teng Zuo; Akritee Shrestha; Rishi R Goel; Donna Neuberg; Duane R Wesemann
Journal:  J Exp Med       Date:  2018-03-27       Impact factor: 14.307

5.  The immunodominant antibody response to Zika virus NS1 protein is characterized by cross-reactivity to self.

Authors:  Cecilia B Cavazzoni; Vicente B T Bozza; Tostes C V Lucas; Luciana Conde; Bruno Maia; Luka Mesin; Ariën Schiepers; Jonatan Ersching; Romulo L S Neris; Jonas N Conde; Diego R Coelho; Tulio M Lima; Renata G F Alvim; Leda R Castilho; Heitor A de Paula Neto; Ronaldo Mohana-Borges; Iranaia Assunção-Miranda; Alberto Nobrega; Gabriel D Victora; Andre M Vale
Journal:  J Exp Med       Date:  2021-07-22       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.